SCHEMBL5312700

SCHEMBL5312700

C=CCC(=O)N1[CH]CCCC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2645015 0.76 ATM (0.37) ATMMEN1KMT2A
SCHEMBL16935647 0.75 ATM (0.35) ATM
SCHEMBL22657793 0.75 MAPK1 (0.32) KMT2A
SCHEMBL2644912 0.75 L3MBTL1 (0.38) ATMMEN1KMT2A
SCHEMBL9192901 0.74 LMNA (0.35) MEN1KMT2A
SCHEMBL2646658 0.73 L3MBTL1 (0.46) ATMMEN1KMT2A
SCHEMBL22657919 0.73 MAPK1 (0.31)
SCHEMBL7837036 0.72 L3MBTL1 (0.53) ATMMEN1KMT2A
SCHEMBL2184936 0.71 ATM (0.50) ATMMEN1KMT2A
SCHEMBL2645771 0.70 ALDH1A1 (0.36) ATMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592426-B1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2007-12-19 EP claimed